By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Loxo Oncology 

1 Landmark Square
Suite 1122
Stamford  Connecticut  06901  U.S.A.
Phone: 203-653-3880 Fax: n/a


Company News
Loxo Oncology (LOXO) TRK Inhibitor LOXO-101 Shows Durable Anti-Tumor Activity Across TRK Fusion Cancers In AACR Phase 1 Update 4/18/2016 8:31:29 AM
Loxo Oncology (LOXO) Prices Follow-On Offering Of Common Stock 11/12/2015 7:32:09 AM
Loxo Oncology (LOXO) Announces Proposed Public Offering Of Common Stock 11/11/2015 7:55:45 AM
Loxo Oncology (LOXO) Announces Third Quarter 2015 Financial Results And Provides Program Updates 11/10/2015 11:06:55 AM
Loxo Oncology (LOXO) To Present At Upcoming Investor Conferences 11/10/2015 11:04:59 AM
Loxo Oncology (LOXO) TRK Inhibitor LOXO-101 Demonstrates Promising Clinical Activity And Safety In Phase 1 Trial 11/9/2015 1:03:50 PM
Loxo Oncology (LOXO) Announces Transition Of Chief Medical Officer 11/5/2015 11:23:28 AM
Loxo Oncology (LOXO) To Announce Third Quarter 2015 Financial Results 11/3/2015 9:58:09 AM
Loxo Oncology (LOXO) Announces Broad Pipeline Update At AACR-National Cancer Institute-EORTC, Including New LOXO-101 Phase 1 Data 10/26/2015 2:36:32 PM
Loxo Oncology (LOXO) Announces First Patient Enrolled In LOXO-101 Phase 2 Basket Trial In Patients With Solid Tumors Harboring TRK Fusions 10/14/2015 11:55:53 AM